دورية أكاديمية
Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study.
العنوان: | Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study. |
---|---|
المؤلفون: | Eldokla AM; Department of Neurology, State University of New York, Upstate Medical University, Syracuse, New York, 13210, USA.; Department of Pathology, State University of New York, Upstate Medical University, Syracuse, New York, 13210, USA., Mohamed-Hussein AA; Chest Department, Faculty of Medicine, Assiut University, Assiut, Egypt., Fouad AM; Department of Public Health, Occupational and Environmental Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt., Abdelnaser MG; Department of Public Health and Community Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt., Ali ST; Department of Neurology, State University of New York, Upstate Medical University, Syracuse, New York, 13210, USA., Makhlouf NA; Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt., Sayed IG; Department of Public Health and Community Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt., Makhlouf HA; Chest Department, Faculty of Medicine, Assiut University, Assiut, Egypt., Shah J; New York State Department of Health, Albany, New York, USA., Aiash H; Department of Family Medicine, Suez Canal University, Ismailia, Egypt.; Department of Cardiovascular Perfusion, State University of New York, Upstate Medical University, Syracuse, New York, 13210, USA. |
المصدر: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Jun; Vol. 9 (6), pp. 778-785. Date of Electronic Publication: 2022 Apr 08. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Hoboken, NJ] : Wiley Periodicals, Inc on behalf of American Neurological Association, [2014]- |
مواضيع طبية MeSH: | COVID-19*/complications , COVID-19*/epidemiology , Orthostatic Intolerance* , Primary Dysautonomias*/epidemiology , Primary Dysautonomias*/etiology, Cross-Sectional Studies ; Female ; Humans ; Male ; Prevalence ; Syndrome ; Post-Acute COVID-19 Syndrome |
مستخلص: | Background: The association between autonomic dysfunction and long-COVID syndrome is established. However, the prevalence and patterns of symptoms of dysautonomia in long-COVID syndrome in a large population are lacking. Objective: To evaluate the prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome. Methods: We administered the Composite Autonomic Symptom Score 31 (COMPASS-31) questionnaire to a sample of post-COVID-19 patients who were referred to post-COVID clinic in Assiut University Hospitals, Egypt for symptoms concerning for long-COVID syndrome. Participants were asked to complete the COMPASS-31 questionnaire referring to the period of more than 4 weeks after acute COVID-19. Results: We included 320 patients (35.92 ± 11.92 years, 73% females). The median COMPASS-31 score was 26.29 (0-76.73). The most affected domains of dysautonomia were gastrointestinal, secretomotor, and orthostatic intolerance with 91.6%, 76.4%, and 73.6%, respectively. There was a positive correlation between COMPASS-31 score and long-COVID duration (p < 0.001) and a positive correlation between orthostatic intolerance domain score and post-COVID duration (p < 0.001). There was a positive correlation between orthostatic intolerance domain score and age of participants (p = 0.004). Two hundred forty-seven patients (76.7%) had a high score of COMPASS-31 >16.4. Patients with COMPASS-31 >16.4 had a longer duration of long-COVID syndrome than those with score <16.4 (46.2 vs. 26.8 weeks, p < 0.001). Conclusions: Symptoms of dysautonomia are common in long-COVID syndrome. The most common COMPASS-31 affected domains of dysautonomia are gastrointestinal, secretomotor, and orthostatic intolerance. There is a positive correlation between orthostatic intolerance domain score and patients' age. (© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.) |
References: | Auton Neurosci. 2021 Nov;235:102841. (PMID: 34265539) Am J Med Sci. 2020 Oct;360(4):427-429. (PMID: 32739039) JAMA Netw Open. 2020 Jun 1;3(6):e2011335. (PMID: 32525549) J Infect. 2021 Mar;82(3):378-383. (PMID: 33450302) Sci Immunol. 2020 May 13;5(47):. (PMID: 32404436) Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. (PMID: 34181102) Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867) Clin Auton Res. 2021 Jun;31(3):385-394. (PMID: 33860871) Curr Opin Gastroenterol. 2021 Jan;37(1):23-29. (PMID: 33074995) Mayo Clin Proc. 2012 Dec;87(12):1196-201. (PMID: 23218087) J Innov Card Rhythm Manag. 2020 Nov 15;11(11):4302-4304. (PMID: 33262898) Rev Neurol. 2021 Jun 1;72(11):384-396. (PMID: 34042167) J Gastroenterol Hepatol. 2021 Jul;36(7):1820-1827. (PMID: 33197076) Sci Rep. 2021 Aug 9;11(1):16144. (PMID: 34373540) Clin Auton Res. 2020 Dec;30(6):571-573. (PMID: 32970212) Circulation. 2020 Jul 14;142(2):101-104. (PMID: 32369390) Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):592-595. (PMID: 32728799) Am J Med. 2007 Oct;120(10):841-7. (PMID: 17904451) Nat Rev Drug Discov. 2005 Aug;4(8):673-84. (PMID: 16056392) Age Ageing. 1980 Feb;9(1):17-24. (PMID: 7361632) Viruses. 2021 Apr 18;13(4):. (PMID: 33919537) Front Med (Lausanne). 2020 Nov 11;7:608259. (PMID: 33262996) eNeurologicalSci. 2020 Dec;21:100276. (PMID: 32984564) J Am Coll Cardiol. 1987 Aug;10(2 Suppl A):42A-47A. (PMID: 3298368) Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1636-1637. (PMID: 32303786) J Neurol. 2022 Feb;269(2):587-596. (PMID: 34386903) J Rheumatol. 2018 Aug;45(8):1145-1152. (PMID: 29907667) J Mol Neurosci. 2008 Jun;35(2):151-60. (PMID: 18369742) Nature. 2002 Dec 19-26;420(6917):853-9. (PMID: 12490958) Am J Physiol Regul Integr Comp Physiol. 2018 Nov 1;315(5):R895-R906. (PMID: 30088946) Diabet Med. 2017 Jun;34(6):834-838. (PMID: 27990686) Signal Transduct Target Ther. 2020 Nov 2;5(1):256. (PMID: 33139693) J Intern Med. 2021 Apr;289(4):523-531. (PMID: 32976665) Hypertension. 2019 Nov;74(5):1181-1191. (PMID: 31564162) Nat Med. 2005 Aug;11(8):875-9. (PMID: 16007097) J Cardiovasc Transl Res. 2020 Dec;13(6):894-899. (PMID: 32458400) Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578) Clin Auton Res. 2021 Jun;31(3):365-368. (PMID: 33740207) Sci Rep. 2021 Jul 7;11(1):14042. (PMID: 34234251) JACC Case Rep. 2021 Apr;3(4):573-580. (PMID: 33723532) Clin Med (Lond). 2021 Jan;21(1):e63-e67. (PMID: 33243837) Microcirculation. 2006 Jun;13(4):329-41. (PMID: 16611594) Clin Auton Res. 2021 Oct;31(5):591-644. (PMID: 34564798) |
تواريخ الأحداث: | Date Created: 20220408 Date Completed: 20220614 Latest Revision: 20221207 |
رمز التحديث: | 20240829 |
مُعرف محوري في PubMed: | PMC9110879 |
DOI: | 10.1002/acn3.51557 |
PMID: | 35393771 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2328-9503 |
---|---|
DOI: | 10.1002/acn3.51557 |